These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7580552)

  • 21. National measles and rubella immunisation campaign.
    Commun Dis Rep CDR Wkly; 1994 Aug; 4(31):147, 150. PubMed ID: 7522814
    [No Abstract]   [Full Text] [Related]  

  • 22. Rates of first measles-mumps-rubella immunisation in Wales (UK).
    Thomas DR; Salmon RL; King J
    Lancet; 1998 Jun; 351(9120):1927. PubMed ID: 9654262
    [No Abstract]   [Full Text] [Related]  

  • 23. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A; Vincent A; Selvaraj K; Manikandan M
    Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients', parents', and oncologists' perceptions of informed consent for bone marrow transplantation.
    Lesko LM; Dermatis H; Penman D; Holland JC
    Med Pediatr Oncol; 1989; 17(3):181-7. PubMed ID: 2664440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Information for all doctors. Update of success of measles/rubella immunisation campaign.
    Health Bull (Edinb); 1995 Sep; 53(5):235-9. PubMed ID: 7490192
    [No Abstract]   [Full Text] [Related]  

  • 26. The measles/rubella immunisation campaign in Scotland.
    Skinner R; Christie P; Cowden JM
    Health Bull (Edinb); 1996 Jan; 54(1):88-98. PubMed ID: 8820234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Family practitioners' immunization consent practice. Washington State, 1986.
    Holt VL; Coombs JB; Marcuse EK
    West J Med; 1988 Apr; 148(4):477-9. PubMed ID: 3388860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles (rubeola) and rubella: (1) dangers of the layman's confusion (2) mass measles immunization.
    Pediatrics; 1970 Dec; 46(6):978-9. PubMed ID: 5491454
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.
    Amela C; Pachón I; de Ory F
    Eur J Epidemiol; 2003; 18(1):71-9. PubMed ID: 12705626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
    Uddin MJ; Adhikary G; Ali MW; Ahmed S; Shamsuzzaman M; Odell C; Hashiguchi L; Lim SS; Alam N
    BMC Infect Dis; 2016 Aug; 16():411. PubMed ID: 27519586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary immunisations in Liverpool. II: Is there a gap between consent and completion?
    Pearson M; Makowiecka K; Gregg J; Woollard J; Rogers M; West C
    Arch Dis Child; 1993 Jul; 69(1):115-9. PubMed ID: 8024292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland.
    Peltola H; Karanko V; Kurki T; Hukkanen V; Virtanen M; Penttinen K; Nissinen M; Heinonen OP
    Lancet; 1986 Jan; 1(8473):137-9. PubMed ID: 2867355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pros and cons of immunisation -- Paper three: the difference between ideological and intellectual dissent.
    Stone DH
    Health Care Anal; 1995 May; 3(2):111-5. PubMed ID: 11645302
    [No Abstract]   [Full Text] [Related]  

  • 34. Serological survey of measles and rubella immunity in Sydney preschool children.
    Causer J; Mira M; Karr M; Hueston L; Burgess M; Alperstein G; Fett M; Cunningham A
    J Paediatr Child Health; 2000 Oct; 36(5):418-21. PubMed ID: 11036793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination against rubella and measles: quantitative investigations of different policies.
    Anderson RM; May RM
    J Hyg (Lond); 1983 Apr; 90(2):259-325. PubMed ID: 6833747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles, mumps, and rubella immunisation.
    Walker D
    Lancet; 1989 Jan; 1(8630):167. PubMed ID: 2563089
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles.
    Young MK
    Hum Vaccin Immunother; 2019; 15(9):2060-2065. PubMed ID: 31116633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunisation levels---need they all decline?
    Bussey AL; Holmes BS
    Lancet; 1977 Nov; 2(8045):970-1. PubMed ID: 72302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.